-+ 0.00%
-+ 0.00%
-+ 0.00%

Tenon Medical Expands U.S. IP Portfolio With USPTO Notices Of Allowance For Multiple Patents Expected In 2026

Benzinga·02/18/2026 13:39:47
Listen to the news

Expanded Global Portfolio Enhances Competitive Position and Supports Long-Term Growth Strategy

LOS GATOS, CA / ACCESS Newswire / February 18, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announced a strategic expansion of its U.S. intellectual property portfolio following receipt of Notices of Allowance from the United States Patent and Trademark Office (USPTO) for multiple patent applications expected to issue in 2026. These newly allowed claims will further strengthen the Company's growing patent portfolio and build upon the (10) ten patents issued in 2025, including (5) five issued by the USPTO and (5) five issued internationally.